< Back to previous page
Researcher
Zhidong Ling
- Keywords:Medicine, General and logistic services
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Diabetes Clinic (Department)
Member
From1 Jan 2018 → Today - Vriendenkring VUB (Office)
Member
From1 Nov 2019 → Today - Vriendenkring VUB (Office)
Member
From1 Nov 2019 → 20 Oct 2022 - Pathology/molecular and cellular medicine (Department)
Member
From1 Oct 2019 → 30 Sep 2020 - Pathology/molecular and cellular medicine (Department)
Member
From8 Apr 2019 → 30 Sep 2019 - Pathology/molecular and cellular medicine (Department)
Member
From1 Jan 2014 → 30 Sep 2020 - Clinical Biology (Department)
Member
From1 Jan 2012 → 31 Dec 2017 - Diabetes Pathology & Therapy (Research group)
Member
From2 Feb 2011 → 1 Jan 2023 - Clinical Biology (Department)
Member
From1 Jan 2008 → 31 Aug 2008 - Pathologic Biochemistry and Physiology (Department)
Member
From1 Oct 2007 → 31 Dec 2013 - Pathologic Biochemistry and Physiology (Department)
Member
From1 Oct 1998 → 30 Sep 2007 - Pathologic Biochemistry and Physiology (Department)
Member
From1 Oct 1995 → 31 Dec 2001
Projects
1 - 5 of 5
- Beta Cell Generation by Stem Cell-Derived Implants in DiabetesFrom1 Dec 2015 → 31 Aug 2022Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Influences of chronic hyperglycemia on development and properties of human beta cells, a study in implants generated by human induced pluripotent stem cells.From1 Oct 2015 → 30 Sep 2019Funding: FWO fellowships
- Innovation in diagnosis, prevention and treatment of type 1 diabetes.From1 Nov 2013 → 31 Oct 2019Funding: FWO Applied Biomedical Research (TBM)
- BetaCellTherapy : Beta Cell Therapy in Diabetes.From1 Jan 2010 → 30 Jun 2015Funding: Health
- In vitro and in vivo markers of beta cell death and function.From1 Jan 2008 → 31 Dec 2011Funding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 64
- HLA-A*24 carrier status and autoantibody surges posttransplantation associate vith poor functional outcome in recipients of an islet allograft(2016)Published in: Diabetes CareISSN: 0149-5992Issue: 6Volume: 39Pages: 1060-1064
- Plasma GAD65, marker for early beta cell loss following intraportal islet cell transplantation in diabetic patients(2015)Published in: The Journal of Clinical Endocrinology & MetabolismISSN: 0021-972XIssue: 6Volume: 100Pages: 2314-2321
- Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct Cells(2015)Published in: Cell TransplantISSN: 0963-6897Issue: 8Volume: 24Pages: 1585-1598
- Development of an enhanced sensitivity bead-based immunoassay for real-time in vivo detection of pancreatic beta cell death(2015)Published in: EndocrinologyISSN: 0013-7227Volume: 156Pages: 4755-4760
- Functional characteristics of neonatal rat beta cells with distinct markers.(2014)Published in: J Mol EndocrinolISSN: 0952-5041Volume: 52Pages: 11-28
- Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts.(2014)Published in: Am J Physiol Endocrinol MetabISSN: 0193-1849Volume: 307Pages: 838-846
- Glucose regulates rat beta cell number through age-dependent effects on beta cell survival and proliferation.(2014)Published in: PLOS ONEISSN: 1932-6203Issue: 1Volume: 9Pages: 1-8
- Conversion of Human Pancreatic Acinar Cells Toward a Ductal-Mesenchymal Phenotype and the Role of Transforming Growth Factor β and Activin Signaling.(2014)Published in: PancreasISSN: 0885-3177Volume: 43Pages: 1083-1092
- Early alteration of kidney function in non-uremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy(2014)Published in: TransplantationISSN: 0041-1337Issue: 4Volume: 98Pages: 451-457
- Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients(2013)Published in: Diabetes CareISSN: 0149-5992Issue: 11Volume: 36Pages: 3483-3488